Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

BA-BE Studies: SOP for Verification of Mobile Phase Composition – V 2.0

Posted on By

BA-BE Studies: SOP for Verification of Mobile Phase Composition – V 2.0

Standard Operating Procedure for Verification of Mobile Phase Composition in BA/BE LC-MS/MS Analysis

Department BA-BE Studies
SOP No. SOP/BA-BE/191/2025
Supersedes SOP/BA-BE/191/2022
Page No. Page 1 of 9
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a standard procedure for the preparation, verification, and documentation of mobile phase composition used in LC-MS/MS systems for BA/BE bioanalytical studies.

2. Scope

This SOP applies to all analysts and laboratory personnel involved in preparing and verifying mobile phases for validated LC-MS/MS methods used in BA/BE studies within the bioanalytical laboratory.

3. Responsibilities

  • Analytical Scientist: Prepares
mobile phase according to method-specific requirements and performs verification steps.
  • QA Officer: Reviews mobile phase logs and verifies adherence to procedures.
  • Lab Manager: Maintains oversight of mobile phase records and ensures compliance with this SOP.
  • 4. Accountability

    The Head of Bioanalytical Department is accountable for ensuring proper preparation, verification, and documentation of mobile phases used in regulated bioanalytical methods.

    5. Procedure

    5.1 Reagent and Solvent Quality

    1. Use HPLC-grade solvents (e.g., acetonitrile, methanol, water) and reagents with CoA from approved vendors.
    2. Ensure chemical labels clearly indicate:
      • Name and grade
      • Lot number
      • Expiry date
    3. Do not use expired solvents or those with signs of contamination or precipitation.

    5.2 Mobile Phase Preparation

    1. Refer to validated method SOP for exact composition, order of mixing, and pH adjustment requirements.
    2. Use volumetric glassware or calibrated dispensers for accurate measurement.
    3. Prepare mobile phase in a clean, designated preparation area.
    4. For buffered mobile phases:
      • Ensure pH is measured using a calibrated pH meter.
      • Adjust pH using approved acid/base agents only.
    5. Record preparation details in Annexure-1: Mobile Phase Preparation Log.

    5.3 Filtration and Degassing

    1. Filter the mobile phase using 0.22 µm or 0.45 µm nylon or PVDF membrane filters (as per method).
    2. Degas by sonication for at least 10 minutes or by helium sparging, if required.
    3. Label final container with:
      • Mobile phase name
      • Date of preparation
      • Prepared by
      • Storage conditions
      • Expiry date (max 7 days or method-specific)

    5.4 Verification of Composition

    1. Verify mobile phase composition via:
      • Gravimetric check for solvent ratios (optional)
      • pH confirmation for aqueous phases
      • Retention time stability of system suitability standard
    2. Record verification results in Annexure-2: Mobile Phase Verification Checklist.
    3. Do not proceed with analysis if:
      • pH deviates ±0.2 units from specified range
      • Appearance is turbid or phase separation is observed

    5.5 Storage and Disposal

    1. Store mobile phase in clean, airtight glass bottles, preferably amber-colored for light-sensitive preparations.
    2. Label containers with expiry and discard after designated time.
    3. Dispose unused or expired mobile phases according to SOP for Hazardous Waste Disposal.

    6. Abbreviations

    • BA/BE: Bioavailability/Bioequivalence
    • LC-MS/MS: Liquid Chromatography Tandem Mass Spectrometry
    • pH: Hydrogen Ion Concentration
    • SOP: Standard Operating Procedure
    • CoA: Certificate of Analysis

    7. Documents

    1. Mobile Phase Preparation Log – Annexure-1
    2. Mobile Phase Verification Checklist – Annexure-2

    8. References

    • ICH M10: Bioanalytical Method Validation
    • US FDA Bioanalytical Method Validation Guidance (2022)
    • USP <621> Chromatography

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Mobile Phase Preparation Log

    Date Mobile Phase Composition Volume Prepared Prepared By Expiry Date
    16/04/2025 Water:Acetonitrile (60:40) 2 L Rajesh Kumar 23/04/2025

    Annexure-2: Mobile Phase Verification Checklist

    Date Parameter Expected Value Observed Value Verified By
    16/04/2025 pH 4.5 ± 0.2 4.6 Sunita Reddy

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    01/01/2022 1.0 Initial Release New SOP QA Head
    17/04/2025 2.0 Expanded verification and documentation requirements Compliance Enhancement QA Head
    See also  BA-BE Studies: SOP for Verification of Study Drug Dispensing by Pharmacist - V 2.0
    BA-BE Studies V 2.0 Tags:Absolute bioavailability, AUC (area under the curve), Bioavailability, Bioequivalence, Bioequivalence criteria, CDSCO bioequivalence norms, Clinical trial registration, Cmax (maximum concentration), Confidence interval %, Crossover study design, EMA bioequivalence requirements, Ethics committee approval, FDA bioequivalence guidelines, Generic drug approval, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Half-life (t½), ICH E(R) compliance, In vitro dissolution, In vivo studies, Informed consent process, Pharmacodynamics, Pharmacokinetics, Randomized controlled trial, Regulatory submission process, Relative bioavailability, Sample size calculation, Therapeutic equivalence, Tmax (time to maximum concentration), Washout period

    Post navigation

    Previous Post: Sterile Injectable Manufacturing: SOP for Setting Parameters for Vial Filling Machines – V 2.0
    Next Post: Analytical Method Development: Microbial Limit Test Method Development – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version